会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME
    • 来自长链聚氧乙烯脂肪酸的脂蛋白及其制备和使用方法
    • WO2008103753A3
    • 2008-11-27
    • PCT/US2008054456
    • 2008-02-20
    • MARTEK BIOSCIENCES CORPARTERBURN LINDABARCLAY WILLIAMDANGI BINDIFLATT JAMESLEE JUNGVINJAMOORI DUTTVAN ELSWYK MARY
    • ARTERBURN LINDABARCLAY WILLIAMDANGI BINDIFLATT JAMESLEE JUNGVINJAMOORI DUTTVAN ELSWYK MARY
    • A61K31/22C07C53/00
    • A61K31/202A23L33/12A61K8/361A61K31/60A61K45/06A61Q19/00C07C59/42C07D303/36C07D303/48A61K2300/00
    • Disclosed are novel oxylipins, referred to herein as docosanoids and eicosanoids, that are derived from C22 polyunsaturated fatty acids and from C20 polyunsaturated fatty acids, respectively, and methods of making and using such oxylipins. Also disclosed is the use of docosapentaenoic acid (C22:5n-6) (DPAn-6), docosapentaenoic acid (C22:5n-3) (DPAn-3), and docosatetraenoic acid (DTAn-6: C22:4n-6), docosatrienoic acid (C22:3n-3) (DTrAn-3), docosadienoic acid (C22:2n-6) (DDAn-6), eicosatrienoic acid (C20:3n-3) (ETrAn-3) eicosapentaenoic acid and arachidonic acid as substrates for the production of novel oxylipins, and to the oxylipins produced thereby. Also disclosed is the use of DPAn-6, DPAn-3, DTAn-6, and/or the oxylipins derived therefrom, and/or novel docosanoids derived from the structures of C22 fatty acids in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. The invention also relates to novel ways of producing long chain polyunsaturated acid (LCPUF A)-rich oils and compositions that contain enhanced and effective amounts of LCPUF A-derived oxylipins, and particularly, docosanoids.
    • 公开了分别衍生自C22多不饱和脂肪酸和C20多不饱和脂肪酸的新型牛脂蛋白,分别是衍生自C22多不饱和脂肪酸的二十二烷酸和类二十烷酸,以及制备和使用这些氧基脂蛋白的方法。 还公开了二十二碳五烯酸(C22:5n-6)(DPAn-6),二十二碳五烯酸(C22:5n-3)(DPAn-3)和二十二碳四烯酸(DTAn-6:C22:4n-6) ,二十二碳三烯酸(C22:3n-3)(DTrAn-3),二十二碳烯酸(C22:2n-6)(DDAn-6),二十碳三烯酸(C20:3n-3)(ETrAn-3)二十碳五烯酸和花生四烯酸 作为生产新型oxylipin的底物,以及由此产生的oxylipin。 还公开了在治疗和营养或美容应用中使用DPAn-6,DPAn-3,DTAn-6和/或由其衍生的oxylipin,和/或衍生自C22脂肪酸结构的新型二醇多糖,特别是作为 抗炎或抗神经变性化合物。 本发明还涉及生产长链多不饱和酸(LCPUF A)的油和组合物的新方法,其含有增强和有效量的LCPUF A衍生的草甘膦,特别是二十二烷酸。